vs
ARCBEST CORP（ARCB）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是ARCBEST CORP的1.4倍（$1.4B vs $998.8M），瑞思迈净利率更高（27.6% vs -0.1%，领先27.7%），瑞思迈同比增速更快（11.0% vs 3.3%），过去两年瑞思迈的营收复合增速更高（9.0% vs -3.7%）
ArcBest是美国头部物流与运输解决方案提供商，提供零担货运、整车运输、仓储、加急配送及定制化物流咨询等全链路供应链服务，覆盖北美及全球部分市场，服务对象包含企业、小型商家及公共部门客户。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
ARCB vs RMD — 直观对比
营收规模更大
RMD
是对方的1.4倍
$998.8M
营收增速更快
RMD
高出7.7%
3.3%
净利率更高
RMD
高出27.7%
-0.1%
两年增速更快
RMD
近两年复合增速
-3.7%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $998.8M | $1.4B |
| 净利润 | $-1.0M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 0.3% | 34.6% |
| 净利率 | -0.1% | 27.6% |
| 营收同比 | 3.3% | 11.0% |
| 净利润同比 | -133.1% | 13.9% |
| 每股收益（稀释后） | $-0.05 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARCBRMD
| Q1 26 | $998.8M | — | ||
| Q4 25 | $972.7M | $1.4B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $967.1M | $1.3B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B |
净利润ARCBRMD
| Q1 26 | $-1.0M | — | ||
| Q4 25 | $-8.1M | $392.6M | ||
| Q3 25 | $39.3M | $348.5M | ||
| Q2 25 | $25.8M | $379.7M | ||
| Q1 25 | $3.1M | $365.0M | ||
| Q4 24 | $29.0M | $344.6M | ||
| Q3 24 | $100.3M | $311.4M | ||
| Q2 24 | $46.9M | $292.2M |
毛利率ARCBRMD
| Q1 26 | — | — | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% |
营业利润率ARCBRMD
| Q1 26 | 0.3% | — | ||
| Q4 25 | -0.8% | 34.6% | ||
| Q3 25 | 5.2% | 33.4% | ||
| Q2 25 | 3.6% | 33.7% | ||
| Q1 25 | 0.7% | 33.0% | ||
| Q4 24 | 3.8% | 32.5% | ||
| Q3 24 | 12.7% | 31.6% | ||
| Q2 24 | 4.5% | 31.2% |
净利率ARCBRMD
| Q1 26 | -0.1% | — | ||
| Q4 25 | -0.8% | 27.6% | ||
| Q3 25 | 3.7% | 26.1% | ||
| Q2 25 | 2.5% | 28.2% | ||
| Q1 25 | 0.3% | 28.3% | ||
| Q4 24 | 2.9% | 26.9% | ||
| Q3 24 | 9.4% | 25.4% | ||
| Q2 24 | 4.4% | 23.9% |
每股收益（稀释后）ARCBRMD
| Q1 26 | $-0.05 | — | ||
| Q4 25 | $-0.35 | $2.68 | ||
| Q3 25 | $1.72 | $2.37 | ||
| Q2 25 | $1.12 | $2.58 | ||
| Q1 25 | $0.13 | $2.48 | ||
| Q4 24 | $1.21 | $2.34 | ||
| Q3 24 | $4.23 | $2.11 | ||
| Q2 24 | $1.96 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $86.4M | $1.4B |
| 总债务越低越好 | $223.7M | $403.9M |
| 股东权益账面价值 | $1.3B | $6.3B |
| 总资产 | $2.5B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资ARCBRMD
| Q1 26 | $86.4M | — | ||
| Q4 25 | $124.2M | $1.4B | ||
| Q3 25 | $132.6M | $1.4B | ||
| Q2 25 | $139.7M | $1.2B | ||
| Q1 25 | $98.7M | $932.7M | ||
| Q4 24 | $157.2M | $521.9M | ||
| Q3 24 | $191.1M | $426.4M | ||
| Q2 24 | $260.5M | $238.4M |
总债务ARCBRMD
| Q1 26 | $223.7M | — | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | $214.1M | $408.7M | ||
| Q2 25 | $241.4M | $658.4M | ||
| Q1 25 | $214.2M | $663.1M | ||
| Q4 24 | $189.1M | $662.9M | ||
| Q3 24 | $180.5M | $667.6M | ||
| Q2 24 | $203.6M | $697.3M |
股东权益ARCBRMD
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $6.3B | ||
| Q3 25 | $1.3B | $6.1B | ||
| Q2 25 | $1.3B | $6.0B | ||
| Q1 25 | $1.3B | $5.5B | ||
| Q4 24 | $1.3B | $5.3B | ||
| Q3 24 | $1.3B | $5.2B | ||
| Q2 24 | $1.2B | $4.9B |
总资产ARCBRMD
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $8.5B | ||
| Q3 25 | $2.5B | $8.3B | ||
| Q2 25 | $2.5B | $8.2B | ||
| Q1 25 | $2.4B | $7.6B | ||
| Q4 24 | $2.4B | $7.1B | ||
| Q3 24 | $2.4B | $7.2B | ||
| Q2 24 | $2.4B | $6.9B |
负债/权益比ARCBRMD
| Q1 26 | 0.17× | — | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | 0.16× | 0.07× | ||
| Q2 25 | 0.19× | 0.11× | ||
| Q1 25 | 0.17× | 0.12× | ||
| Q4 24 | 0.14× | 0.13× | ||
| Q3 24 | 0.14× | 0.13× | ||
| Q2 24 | 0.17× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $339.7M |
| 自由现金流经营现金流 - 资本支出 | — | $311.2M |
| 自由现金流率自由现金流/营收 | — | 21.9% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流ARCBRMD
| Q1 26 | — | — | ||
| Q4 25 | $44.7M | $339.7M | ||
| Q3 25 | $98.2M | $457.3M | ||
| Q2 25 | $108.4M | $538.8M | ||
| Q1 25 | $-22.3M | $578.7M | ||
| Q4 24 | $56.8M | $308.6M | ||
| Q3 24 | $88.8M | $325.5M | ||
| Q2 24 | $133.7M | $440.1M |
自由现金流ARCBRMD
| Q1 26 | — | — | ||
| Q4 25 | $36.9M | $311.2M | ||
| Q3 25 | $33.2M | $414.4M | ||
| Q2 25 | $80.9M | $508.2M | ||
| Q1 25 | $-36.8M | $557.9M | ||
| Q4 24 | $3.5M | $288.0M | ||
| Q3 24 | $23.9M | $307.7M | ||
| Q2 24 | $83.9M | $415.2M |
自由现金流率ARCBRMD
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | 21.9% | ||
| Q3 25 | 3.2% | 31.0% | ||
| Q2 25 | 7.9% | 37.7% | ||
| Q1 25 | -3.8% | 43.2% | ||
| Q4 24 | 0.4% | 22.5% | ||
| Q3 24 | 2.2% | 25.1% | ||
| Q2 24 | 7.8% | 33.9% |
资本支出强度ARCBRMD
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | 2.0% | ||
| Q3 25 | 6.2% | 3.2% | ||
| Q2 25 | 2.7% | 2.3% | ||
| Q1 25 | 1.5% | 1.6% | ||
| Q4 24 | 5.3% | 1.6% | ||
| Q3 24 | 6.1% | 1.5% | ||
| Q2 24 | 4.6% | 2.0% |
现金转化率ARCBRMD
| Q1 26 | — | — | ||
| Q4 25 | — | 0.87× | ||
| Q3 25 | 2.50× | 1.31× | ||
| Q2 25 | 4.20× | 1.42× | ||
| Q1 25 | -7.13× | 1.59× | ||
| Q4 24 | 1.96× | 0.90× | ||
| Q3 24 | 0.89× | 1.05× | ||
| Q2 24 | 2.85× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARCB
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
